跳至主要内容
临床试验/NCT01443325
NCT01443325已完成3 期

Lidocaine Patch for Treatment of Persistent Inguinal Postherniorrhaphy Pain

Rigshospitalet, Denmark1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
21
试验地点
1
主要终点
pain reduction with lidocaine patch

研究概览

简要总结

In the present placebo-controlled cross-over study the researchers intend to investigate analgesic and sensory effects of a lidocaine patch in patients with severe persistent inguinal post-herniorrhaphy pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Males > 18 yrs
  • ASA (American Society´s of Anesthesiology´s classification) scores I-III, with severe Pain for more than six months and with average daily pain intensities (numerical rating scale [NRS] 0-10 points) during rest or during movement > 6.

排除标准

  • History of an allergic reaction or intolerance to amide local anesthetics or vehicle ingredients in the patches
  • Use of class I antiarrhythmic drugs (e.g., tocainide and mexiletine)
  • Severe cardiac impairment, e.g., NYHA (New York Heart Association) Class ≥ III
  • Inflamed or injured skin at the application site
  • Known severe hepatic disorder (Child-Pugh score > 6)
  • Known severe renal impairment, (creatinine clearance < 30 mL/min)
  • Signs of cognitive impairment or known drug or ethanol abuse during the last 2 years.

研究组 & 干预措施

lidocaine patch

Experimental

干预措施: lidocaine patch (Drug)

结局指标

主要结局

pain reduction with lidocaine patch

时间窗: assessed the last three days in each treatment period

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joakim Bischoff

Research fellow, MD

Rigshospitalet, Denmark

研究点 (1)

Loading locations...

相似试验